MJ Holdings Inc (MJNE)
0.0066
0.00 (0.00%)
USD |
OTCM |
Apr 19, 12:10
MJ Holdings Enterprise Value: 1.183M for April 18, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 18, 2024 | 1.183M |
April 17, 2024 | 1.113M |
April 16, 2024 | 1.113M |
April 15, 2024 | 1.113M |
April 12, 2024 | 1.289M |
April 11, 2024 | 1.206M |
April 10, 2024 | 1.206M |
April 09, 2024 | 1.186M |
April 08, 2024 | 1.194M |
April 05, 2024 | 1.194M |
April 04, 2024 | 1.194M |
April 03, 2024 | 1.194M |
April 02, 2024 | 1.133M |
April 01, 2024 | 1.128M |
March 28, 2024 | 1.180M |
March 27, 2024 | 1.194M |
March 26, 2024 | 1.154M |
March 25, 2024 | 1.183M |
March 22, 2024 | 1.206M |
March 21, 2024 | 1.180M |
March 20, 2024 | 1.168M |
March 19, 2024 | 1.171M |
March 18, 2024 | 1.614M |
March 15, 2024 | 1.445M |
March 14, 2024 | 1.445M |
Date | Value |
---|---|
March 13, 2024 | 1.445M |
March 12, 2024 | 1.815M |
March 11, 2024 | 1.798M |
March 08, 2024 | 1.666M |
March 07, 2024 | 1.736M |
March 06, 2024 | 1.818M |
March 05, 2024 | 1.818M |
March 04, 2024 | 1.818M |
March 01, 2024 | 1.818M |
February 29, 2024 | 1.795M |
February 28, 2024 | 1.795M |
February 27, 2024 | 1.736M |
February 26, 2024 | 2.051M |
February 23, 2024 | 2.051M |
February 22, 2024 | 2.032M |
February 21, 2024 | 2.028M |
February 20, 2024 | 2.028M |
February 16, 2024 | 2.028M |
February 15, 2024 | 2.136M |
February 14, 2024 | 1.953M |
February 13, 2024 | 1.953M |
February 12, 2024 | 1.911M |
February 09, 2024 | 1.952M |
February 08, 2024 | 1.800M |
February 07, 2024 | 1.800M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.113M
Minimum
Apr 15 2024
89.85M
Maximum
Feb 11 2021
15.82M
Average
15.00M
Median
Jan 23 2020
Enterprise Value Benchmarks
NovaBay Pharmaceuticals Inc | 2.485M |
Palatin Technologies Inc | 21.01M |
iBio Inc | 16.03M |
Theriva Biologics Inc | -12.54M |
Ampio Pharmaceuticals Inc | -3.814M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 0.6652M |
Revenue (Quarterly) | 0.0233M |
Total Expenses (Quarterly) | 0.4413M |
EPS Diluted (Quarterly) | -0.01 |
Earnings Yield | -606.1% |
Normalized Earnings Yield | -471.42 |